Latest New Zealand News

Heartland Group Holdings updates its dividend distribution details for the first half of 2025, confirming an unfranked ordinary dividend and a supplementary dividend with a revised DRP strike price.

Platinum Capital Limited has updated the price for its Dividend Reinvestment Plan (DRP) ahead of its fully franked dividend payment for the six months ending June 2025. The dividend of 3 cents per share will be paid on September 22, with new shares issued under the DRP at a revised price.

Felix Group Holdings reminds shareholders that its Share Purchase Plan closes on 9 September, offering shares at a slight discount following a $16 million placement. Eligible investors in Australia and New Zealand have a final chance to participate without brokerage fees.

DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.

EMU NL has announced a $1.83 million non-renounceable entitlement offer to fund exploration at its Georgetown and Badja projects, while facing potential board upheaval at an upcoming general meeting.

iTech Minerals has announced a $2 million equity raise, including a $1 million Share Purchase Plan offering shares at a 14.2% discount to fund key mineral exploration projects and working capital.

Wesfarmers Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 1.11 per share payable on 7 October 2025, with shareholders able to receive payments in AUD, NZD, or GBP.

Australian United Investment Company Limited has updated its dividend announcement to include the Dividend Reinvestment Plan issue price, confirming a fully franked total dividend of AUD 0.28 per share for the period ending June 2025.

Vicinity Centres has updated its dividend distribution details for the six months ending June 2025, including the Dividend Reinvestment Plan price and the NZD equivalent payout for New Zealand investors.

SunRice reported steady FY25 financials with improved profitability despite revenue pressure, while advancing its 2030 Growth Strategy amid industry headwinds and leadership transition.

Compumedics has secured FDA clearance for its single-use Somfit®D device, effectively doubling its addressable U.S. home sleep testing market to an estimated US$240 million annually. This milestone positions the company to capture significant market share with a dual-platform EEG-based solution.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.